Basit öğe kaydını göster

dc.contributor.authorCelebi, Ali Riza Cenk
dc.contributor.authorKadayifcilar, Sibel
dc.contributor.authorEldem, Bora
dc.date.accessioned2019-12-12T06:42:08Z
dc.date.available2019-12-12T06:42:08Z
dc.date.issued2015
dc.identifier.issn2090-6722
dc.identifier.urihttps://doi.org/10.1155/2015/640247
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334424/
dc.identifier.urihttp://hdl.handle.net/11655/16701
dc.description.abstractPurpose. To report the efficacy of hyperbaric oxygen (HBO) therapy in a case of branch retinal artery occlusion (BRAO) in a 15-year-old boy. Methods. We report a 15-year-old boy with sudden loss of vision due to BRAO. Examination included laboratory evaluation for systemic risk factors. Follow-up exams included visual acuity, fundus examination, fundus fluorescein angiography, and visual field testing. HBO therapy was employed for treatment. Results. Medical history was positive for isolated glucocorticoid deficiency. Laboratory evaluation disclosed hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) mutation. The visual acuity 0.05 at presentation improved to 0.8 after 20 days of HBO therapy. There was no change on visual fields. Conclusion. In this pediatric case, HBO therapy was useful in the treatment of BRAO.
dc.relation.isversionof10.1155/2015/640247
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleHyperbaric Oxygen Therapy In Branch Retinal Artery Occlusion In A 15-Year-Old Boy With Methylenetetrahydrofolate Reductase Mutation
dc.typeinfo:eu-repo/semantics/article
dc.relation.journalCase Reports in Ophthalmological Medicine
dc.contributor.departmentGöz Hastalıkları
dc.identifier.volume2015
dc.description.indexPubMed


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster